Abstract
PREVIOUS studies conducted in this laboratory demonstrated that in a spectrum of liver tumours with different growth rates there is an imbalance in the activities of key enzymes and competing pathways of carbohydrate, pyrimidine, DNA and ornithine metabolism1–4. Recent investigations on purine metabolism showed that in the hepatomas there was an increased capacity in the de novo pathway of biosynthesis of inosine 5′-monophosphate (IMP), as reflected in the increased activity of glutamine PRPP amidotransferase (EC 2.4.2.14) and a decrease in IMP catabolism5,6. These observations directed our attention to the metabolic fate of IMP because this purine nucleotide is at a strategic position in purine metabolism (Fig. 1). Control at such branching points is exerted primarily by modification of the activity or of the rate of synthesis of the first enzymes of the divergent pathways. In this instance, in normal conditions, a balance is maintained by both positive and negative feedback effects. Thus ATP is required for GMP biosynthesis and GTP for AMP biosynthesis; conversely, GMP and AMP each inhibit their own production7. In normal or malignant proliferation, or in response to a hormone stimulus, changes in control frequently involve reprogramming of gene expression. The theoretical framework and predictive value of generalisations about such biochemical changes (termed the molecular correlation concept) have been elaborated1–3.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Weber, G., in The Molecular Biology of Cancer (edit. by Busch, H.) 487–521 (Academic, New York, 1974).
Weber, G., Queener, S. F., and Ferdinandus, J. A., Adv. Enzyme Regul., 9, 63–95 (1971).
Weber, G., Adv. Enzyme Regul., 11, 79–102 (1973).
Williams, J. C., Weber, G., and Morris, H. P., Nature, 253, 567–569 (1975).
Katunuma, N., and Weber, G., FEBS Lett., 49, 53–56 (1974).
Weber, G., Prajda, N., and Williams, J. C., Adv. Enzyme Regul., 13, 3–25 (1975).
Hartman, S. C., in Metabolic Pathways, third ed., 4 (edit. by Greenberg, D. M.), 1–69 (Academic, New York, 1970).
Abrams, R., and Bentley, M., Archs Biochem., 56, 184–195 (1955).
Atkinson, M. R., Morton, R. K., and Murray, A. W., Biochem., J., 89, 167–172 (1963).
Al-Mudhaffar, S., and Ackerman, C. J., Endocrinology, 82, 912–918 (1968).
Pehlke, D. M., McDonald, J. A., Holmes, E. W., and Kelley, W. N., J. clin. Invest., 51, 1398–1404 (1972).
Anderson, J. A., and Sartorelli, A. C., J. biol. Chem., 243, 4762–4768 (1968).
McFall, E., and Magasanik, B., J. biol. Chem., 235, 2103–2108 (1969).
Holmes, E. W., Pehlke, D. M., and Kelley, W. N., Biochim. biophys. Acta, 364, 209–217 (1974).
Saccoccia, P. A., and Miech, R. P., Molec. Pharmac., 5, 26–29 (1969).
Sweeney, M. J., Hoffman, D. H., and Esterman, M. A., Cancer Res., 32, 1803–1809 (1972).
Cleland, W. W., Biochim. biophys. Acta, 67, 104–137 (1963).
Bucher, N. L. R., and Malt, R. A., Regeneration of Liver and Kidney (Little, Brown, Boston, 1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
JACKSON, R., WEBER, G. & MORRIS, H. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature 256, 331–333 (1975). https://doi.org/10.1038/256331a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/256331a0
This article is cited by
-
Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer
Journal of Translational Medicine (2024)
-
Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway
Journal of Experimental & Clinical Cancer Research (2023)
-
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells
BMC Cancer (2022)
-
Enhanced inflammation and suppressed adaptive immunity in COVID-19 with prolonged RNA shedding
Cell Discovery (2022)
-
IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma
Scientific Reports (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.